Based on preclinical and clinical findings, zofenopril appears to be an angiotensin-
converting enzyme (ACE) inhibitor with high potency, significant tissue selectivity and a long …

Atrial arrhythmias, ventricular arrhythmias, and sudden cardiac death (SCD) are significant
health problems and an economic burden to society. The renin‐angiotensin‐aldosterone …

Methods We conducted a Medline search for all articles on acute myocardial infarction
dating from January 1980 to August 1997, with particular emphasis on secondary prevention …

Long-term follow-up of clinical trials of blood pressure–lowering medications has suggested
a continuation of event reduction after study completion. We evaluated the persistence of …

Objectives: This study was undertaken to examine recent trends in the use of angiotensin-
converting enzyme (ACE) inhibitor therapy in patients discharged after acute myocardial …

This study compared the incidence of cough with the angiotensin‐converting enzyme (ACE)
inhibitor lisinopril and the diuretic metolazone with the angiotensin II receptor antagonist …

BACKGROUND: Clinical trials demonstrating that angiotensin-converting enzyme (ACE)
inhibitors reduce mortality when prescribed following myocardial infarction have focused on …

Revisores del documento: Sigmund Silber (Coordinador de revisión de la CPG)(Alemania),
Frank V. Aguirre (Estados Unidos), Nawwar Al-Attar (Francia), Eduardo Alegría (España) …

Background Both fosinopril and valsartan are effective in protecting endothelial function. We
hypothesized that they may also reduce myocardial no-reflow. In addition, suppression of …

Following establishment of its efficacy in hypertension and congestive heart failure, the ACE
inhibitor lisinopril has now been shown to reduce mortality and cardiovascular morbidity in …